Article Text
PDFEthics
An interaction of medical and statistical ethics
Abstract
It is argued that the practice of omitting outliers when calibrating thromboplastin time, as recommended by the World Health Organization, should not continue unless it can be justified statistically and that possible harmful effects of omitting such data should be investigated.
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
2009 BMJ Publishing Group & Institute of Medical Ethics
Read the full text or download the PDF:
Other content recommended for you
- European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors
- Institutionalising an evidence - informed approach to guideline development: progress and challenges at the World Health Organization
- European Concerted Action on Anticoagulation. A multicentre calibration study of WHO international reference preparations for thromboplastin, rabbit (RBT / 90) and human (rTF / 95)
- Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes
- Effects of strenuous exercise on haemostasis
- National HIV treatment guidelines in Tanzania and Ethiopia: are they legitimate rationing tools
- INR derivation with the PT / INR Line simplified using a spreadsheet from the world wide web
- Management of bleeding in patients receiving non-vitamin K antagonists
- 2nd International Conference on Biomedicine and Pharmaceutics (ICBP) 2014
- Direct oral anticoagulants: unique properties and practical approaches to management